{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:30:20Z","timestamp":1740130220211,"version":"3.37.3"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Vietnam Education Foundation Fellowship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Determining risk scores for genital high-risk human papillomavirus (HRHPV) infection in women will support more efficient cervical cancer screening strategies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We developed and validated point scores to predict the likelihood of any genital HRHPV infection in women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted the cross-sectional analysis in 2017 and used data from the 2005\u201314 US National Health and Nutrition Examination Survey (7337 women aged 25\u201359 years; 6300 women aged 30\u201359 years). Predictors were reproductive health practices, risk behaviors and demographic variables. The outcome was a positive result for any of the 21 genital HRHPV genotypes. The 2005\u201312 cohorts were used as training and testing sets to develop scores that best classified women into three risk groups: low risk (&lt;20%), average risk (20\u201330%) and high risk (&gt;30%). The 2013\u201314 cohort was used to validate the final scores.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Two-point scores with six self-reported variables were created to predict any HRHPV risks for the two age groups: the Personal Risk of Oncogenic HPV (PRO-HPV25) for women aged 25\u201359 years old and PRO-HPV30 for women aged 30\u201359 years old. The scores were successfully prospectively validated, with good calibration with regards to the predicted and observed rates of HRHPV infection. The scores had fair discrimination (c-statistics: 0.67\u20130.68).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The PRO-HPV risk scores can identify groups at low, average and high risk of genital HRHPV infection. This information can be used to prioritize women for cervical cancer screening in low-resource settings or to personalize screening intervals.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/fampra\/cmy091","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T15:25:19Z","timestamp":1535815519000},"page":"395-401","source":"Crossref","is-referenced-by-count":1,"title":["Developing and validating the Personal Risk of Oncogenic Human Papillomavirus infection score in US Women"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4544-1160","authenticated-orcid":false,"given":"Thuy N","family":"Thai","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh C","family":"Bui","sequence":"additional","affiliation":[{"name":"Department of Family and Preventive Medicine, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma, OK, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H","family":"Ebell","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of Georgia, Athens, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"year":"2013","author":"Ferlay","key":"2019073118402431400_CIT0001"},{"key":"2019073118402431400_CIT0002","doi-asserted-by":"crossref","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","article-title":"Human papillomavirus-associated cancers\u2014United States, 2008-2012","volume":"65","author":"Viens","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019073118402431400_CIT0003","first-page":"9","article-title":"Human papillomavirus","volume":"100B","author":"International Agency for Research on Cancer","year":"2012","journal-title":"IARCMonogr Eval Carcinog Risks Hum"},{"key":"2019073118402431400_CIT0004","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. preventive services task force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"2019073118402431400_CIT0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40985-018-0080-0","article-title":"Cancer screening recommendations: an international comparison of high income countries","volume":"39","author":"Ebell","year":"2018","journal-title":"Public Health Rev"},{"volume-title":"WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention","year":"2013","author":"WHO Guidelines Approved by the Guidelines Review Committee","key":"2019073118402431400_CIT0006"},{"year":"2016","author":"Howlader","key":"2019073118402431400_CIT0007"},{"key":"2019073118402431400_CIT0008","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1001\/jamainternmed.2017.3999","article-title":"Using risk stratification to reduce medical errors in cervical cancer prevention","volume":"177","author":"Perkins","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2019073118402431400_CIT0009","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/ijc.28790","article-title":"A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes","volume":"135","author":"Brentnall","year":"2014","journal-title":"Int J Cancer"},{"key":"2019073118402431400_CIT0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jmv.23490","article-title":"Effectiveness of HPV 16 viral load and the E2\/E6 ratio for the prediction of cervical cancer risk among Chinese women","volume":"85","author":"Chang","year":"2013","journal-title":"J Med Virol"},{"key":"2019073118402431400_CIT0011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/gm323","article-title":"Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation","volume":"4","author":"Teschendorff","year":"2012","journal-title":"Genome Med"},{"key":"2019073118402431400_CIT0012","first-page":"38","article-title":"Development and validation of risk scoring system for prediction of cancer cervix","volume":"50","author":"Patil","year":"2006","journal-title":"Indian J Public Health"},{"key":"2019073118402431400_CIT0013","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ijc.28982","article-title":"Risk evaluation for the development of cervical intraepithelial neoplasia: development and validation of risk-scoring schemes","volume":"136","author":"Lee","year":"2015","journal-title":"Int J Cancer"},{"key":"2019073118402431400_CIT0014","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/LGT.0000000000000103","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"19","author":"Huh","year":"2015","journal-title":"J Low Genit Tract Dis"},{"year":"2017","author":"Centers for Disease Control and Prevention","key":"2019073118402431400_CIT0015"},{"volume-title":"National Health and Nutrition Examination Survey: 2011\u20132012 Data Documentation, Codebook, and Frequencies. Human Papillomavirus (HPV) DNA\u2014Vaginal Swab: Digene Hybrid Capture and Roche Linear Array (HPVSWR_G)","author":"Centers for Disease Control and Prevention","key":"2019073118402431400_CIT0016"},{"key":"2019073118402431400_CIT0017","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/2141-9248.122082","article-title":"Local risk factors in genital human papilloma virus infection in cervical smears","volume":"3","author":"Ojiyi","year":"2013","journal-title":"Ann Med Health Sci Res"},{"key":"2019073118402431400_CIT0018","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/505982","article-title":"Genital human papillomavirus infection","volume":"43","author":"Dunne","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2019073118402431400_CIT0019","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2334-13-135","article-title":"Prevalence of high-risk HPV types and associated genital diseases in women born in 1988\/89 or 1983\/84\u2014results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany","volume":"13","author":"Petry","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2019073118402431400_CIT0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1590\/S1413-86702011000600011","article-title":"Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina","volume":"15","author":"Deluca","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"2019073118402431400_CIT0021","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ijc.20970","article-title":"Chlamydia trachomatis infection and persistence of human papillomavirus","volume":"116","author":"Silins","year":"2005","journal-title":"Int J Cancer"},{"key":"2019073118402431400_CIT0022","doi-asserted-by":"crossref","first-page":"e4168","DOI":"10.1136\/bmj.e4168","article-title":"Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study","volume":"344","author":"Oakeshott","year":"2012","journal-title":"BMJ"},{"key":"2019073118402431400_CIT0023","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archpedi.160.2.151","article-title":"Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women","volume":"160","author":"Shew","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2019073118402431400_CIT0024","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0959-8049(98)00131-2","article-title":"Risk factors for HPV detection in archival Pap smears. A population-based study from Greenland and Denmark","volume":"34","author":"Svare","year":"1998","journal-title":"Eur J Cancer"},{"key":"2019073118402431400_CIT0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1258\/ijsa.2007.007179","article-title":"Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American screening study cohort","volume":"19","author":"Syrj\u00e4nen","year":"2008","journal-title":"Int J STD AIDS"},{"key":"2019073118402431400_CIT0026","first-page":"615","article-title":"Risk factors for high-risk type human papillomavirus infection among Mexican-American women","volume":"8","author":"Giuliano","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019073118402431400_CIT0027","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.7314\/APJCP.2013.14.10.5861","article-title":"Genotype distribution and behavioral risk factor analysis of human papillomavirus infection in Uyghur women","volume":"14","author":"Sui","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"2019073118402431400_CIT0028","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1158\/1055-9965.EPI-08-0180","article-title":"Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy","volume":"17","author":"Ammatuna","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019073118402431400_CIT0029","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"2019073118402431400_CIT0030","first-page":"228","article-title":"Prevalence of genital human papillomavirus infection in Wellington women","volume":"68","author":"Meekin","year":"1992","journal-title":"Genitourin Med"},{"key":"2019073118402431400_CIT0031","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/oxfordjournals.aje.a116911","article-title":"Risk factors associated with cervical human papillomavirus infections: a case-control study","volume":"138","author":"Kataja","year":"1993","journal-title":"Am J Epidemiol"},{"key":"2019073118402431400_CIT0032","first-page":"185","article-title":"Epidemiological modelling of risk factors of human papilloma virus in women with positive cytology in the county of Csongr\u00e1d","volume":"31","author":"Kalm\u00e1r","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"key":"2019073118402431400_CIT0033","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"year":"2008","author":"Centers for Disease Control and Prevention","key":"2019073118402431400_CIT0034"},{"key":"2019073118402431400_CIT0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/infdis\/jiu116","article-title":"High-risk oral human papillomavirus load in the US population, national health and nutrition examination survey 2009-2010","volume":"210","author":"Chaturvedi","year":"2014","journal-title":"J Infect Dis"},{"key":"2019073118402431400_CIT0036","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009-2010","volume":"307","author":"Gillison","year":"2012","journal-title":"JAMA"},{"key":"2019073118402431400_CIT0037","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007435-200211000-00018","article-title":"Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis","volume":"29","author":"Manhart","year":"2002","journal-title":"Sex Transm Dis"},{"key":"2019073118402431400_CIT0038","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"},{"key":"2019073118402431400_CIT0039","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/infdis\/169.4.792","article-title":"The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska native women","volume":"169","author":"Davidson","year":"1994","journal-title":"J Infect Dis"},{"key":"2019073118402431400_CIT0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00007435-199705000-00011","article-title":"Factors associated with human papillomavirus infection detected by polymerase chain reaction among urban Canadian aboriginal and non-aboriginal women","volume":"24","author":"Young","year":"1997","journal-title":"Sex Transm Dis"},{"key":"2019073118402431400_CIT0041","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-77244-8","volume-title":"Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating","author":"Steyerberg","year":"2009"},{"key":"2019073118402431400_CIT0042","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"2019073118402431400_CIT0043","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/jnci\/djm223","article-title":"Projecting individualized absolute invasive breast cancer risk in African American women","volume":"99","author":"Gail","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2019073118402431400_CIT0044","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.vaccine.2006.05.031","article-title":"Chapter 6: epidemiology and transmission dynamics of genital HPV infection","volume":"24","author":"Burchell","year":"2006","journal-title":"Vaccine"},{"key":"2019073118402431400_CIT0045","article-title":"National Health and Nutrition Examination Survey: 2011\u20132012 Data Documentation, Codebook, and Frequencies","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"Sexual Behavior"}],"container-title":["Family Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/fampra\/article-pdf\/36\/4\/395\/29025606\/cmy091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T18:40:37Z","timestamp":1564598437000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/fampra\/article\/36\/4\/395\/5098738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,9,17]]},"published-print":{"date-parts":[[2019,7,31]]}},"URL":"https:\/\/doi.org\/10.1093\/fampra\/cmy091","relation":{},"ISSN":["1460-2229"],"issn-type":[{"type":"electronic","value":"1460-2229"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2018,9,17]]}}}